Solara Active Pharma Sciences (NSE:SOLARAPP1) ROCE %: 10.33% (As of Mar. 2026)


NSE:SOLARAPP1 Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
67 GF Score
Price ₹267.45
GF Value ₹263.62
! 3 Warning Signs
View Full Analysis

What is Solara Active Pharma Sciences ROCE %?

Solara Active Pharma Sciences NSE:SOLARAPP1 67 ROCE % is 10.33% as of Mar. 2026. GuruFocus rates NSE:SOLARAPP1 with a GF Score™ of 67/100 and a GF Value™ of ₹263.62. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Solara Active Pharma Sciences's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.33%.

Solara Active Pharma Sciences  (NSE:SOLARAPP1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Solara Active Pharma Sciences ROCE % Related Terms

Solara Active Pharma Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Solara Active Pharma Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solara Active Pharma Sciences ROCE % Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.29 2.10 -26.74 9.63 6.41

Solara Active Pharma Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.39 10.69 3.02 1.41 10.33
NSE:SOLARAPP1
67GF Score
Solara Active Pharma Sciences Ltd NSE:SOLARAPP1
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solara Active Pharma Sciences ROCE % Calculation

Solara Active Pharma Sciences's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=873.4/( ( (22318.4 - 9441.1) + (23325.9 - 8939.1) )/ 2 )
=873.4/( (12877.3+14386.8)/ 2 )
=873.4/13632.05
=6.41 %

Solara Active Pharma Sciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1486.8/( ( (0 - 0) + (23325.9 - 8939.1) )/ 1 )
=1486.8/( ( 0 + 14386.8 )/ 1 )
=1486.8/14386.8
=10.33 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.33% mean?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a ROCE % of 10.33% as of Mar. 2026.
Is Solara Active Pharma Sciences' ROCE % too high?
Solara Active Pharma Sciences' current ROCE % is 10.33%. The Drug Manufacturers industry median ROCE % is 7.03. Solara Active Pharma Sciences' value of 10.33% is 46.9% above this industry median. Overall, Solara Active Pharma Sciences has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Solara Active Pharma Sciences' ROCE % compare to ZTS and UTHR?
Solara Active Pharma Sciences' ROCE % of 10.33% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Solara Active Pharma Sciences' value of 10.33% is 46.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solara Active Pharma Sciences's current ROCE % of 10.33% is 46.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solara Active Pharma Sciences's current ROCE % is 10.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solara Active Pharma Sciences stock overvalued right now?
Solara Active Pharma Sciences (NSE:SOLARAPP1) has a current ROCE % of 10.33%. The stock's GF Value™ is ₹263.62, compared to a current price of ₹267.45 — trading 1.5% above its estimated fair value. The current ROCE % is 10.33% and 46.9% above the Drug Manufacturers industry median of 7.03. Solara Active Pharma Sciences' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Solara Active Pharma Sciences (NSE:SOLARAPP1), the current ROCE % is 10.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solara Active Pharma Sciences (NSE:SOLARAPP1) Overvalued in 2026?

Based on GuruFocus' analysis, Solara Active Pharma Sciences stock appears to be overvalued. The current stock price of ₹267.45 is trading 1.5% above its estimated GF Value™ of ₹263.62.

Key valuation signals for NSE:SOLARAPP1:

  • ROCE %: 10.33%
  • GF Value™: ₹263.62 vs. price of ₹267.45 (1.5% above fair value)
  • GF Score™: 67/100 with 3 warning signs
  • Industry Position: 46.9% above the Drug Manufacturers median

No single metric tells the full story. See the NSE:SOLARAPP1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solara Active Pharma Sciences Business Description

Other Exchanges SOLARA:India541540:India
Address Phase II - CSIR Road, Module No. 601, 602, 603, Ticel Bio Park, Taramani, Chennai, TN, IND, 600113
Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.
67GF Score

Get the complete analysis for NSE:SOLARAPP1

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹267.45
Price
₹263.62
GF Value